{"id":51,"date":"2025-07-31T19:48:32","date_gmt":"2025-07-31T17:48:32","guid":{"rendered":"https:\/\/opellahealthcare.us\/?p=51"},"modified":"2025-07-28T19:49:50","modified_gmt":"2025-07-28T17:49:50","slug":"frances-sanofi-helps-iraq-develop-pharmaceutical-industry-iraqinews","status":"publish","type":"post","link":"https:\/\/opellahealthcare.us\/index.php\/2025\/07\/31\/frances-sanofi-helps-iraq-develop-pharmaceutical-industry-iraqinews\/","title":{"rendered":"France\u2019s Sanofi helps Iraq develop pharmaceutical industry &#8211; iraqinews"},"content":{"rendered":"\n<p>The Iraqi Ministry of Health mentioned on Sunday that the agreement with Sanofi, a French pharmaceutical and healthcare company, represents an essential step toward strengthening Iraq\u2019s pharmaceutical industry.<\/p>\n\n\n\n<p>During his participation in a scientific workshop on biosimilar medicines and intellectual property, Deputy Health Minister Hani al-Oqabi explained that the agreement reached with Sanofi is not limited to the pharmaceutical industry but includes other important areas, according to the state-run news agency (INA).<\/p>\n\n\n\n<p>Iraqi Prime Minister Mohammed Shia al-Sudani has lately been focusing on developing collaboration with international enterprises and seeking investments to build industries in Iraq, according to al-Oqabi.<\/p>\n\n\n\n<p>The prime minister\u2019s advisor on industry and private sector development, Hammoudi al-Lami, revealed earlier that AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, is thinking of building a pharmaceutical facility in Iraq.<\/p>\n\n\n\n<p>In a statement to the Iraqi News Agency (INA), al-Lami explained that Arab and foreign companies are eager to set up businesses in the Iraqi market.<\/p>\n\n\n\n<p>The Iraqi official indicated that the US multinational healthcare company Baxter, as well as businesses in the Gulf States, had also expressed a desire to become part of the Iraqi market.<\/p>\n\n\n\n<p>The Iraqi Ministry of Health revealed in late April that it signed an agreement with European companies to establish an insulin production plant in the northern Iraqi province of Nineveh.<\/p>\n\n\n\n<p>According to INA, the agreement was signed with a Polish firm, one of the top four producers of insulin worldwide, and a German corporation.<\/p>\n\n\n\n<p>The idea to produce insulin in Iraq that meets all European requirements was sparked by the Iraqi government\u2019s support for pharmaceutical and health industry initiatives.&nbsp;<\/p>\n\n\n\n<p>The steps align with the objectives outlined in the Iraqi government\u2019s agenda, which emphasizes the development of the country\u2019s health sector.<\/p>\n\n\n\n<p>Source: <a href=\"https:\/\/www.iraqinews.com\/iraq\/frances-sanofi-helps-iraq-develop-pharmaceutical-industry\/\">https:\/\/www.iraqinews.com\/iraq\/frances-sanofi-helps-iraq-develop-pharmaceutical-industry\/<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Iraqi Ministry of Health mentioned on Sunday that the agreement with Sanofi, a French pharmaceutical and healthcare company, represents an essential step toward strengthening Iraq\u2019s pharmaceutical industry. During his participation in a scientific workshop on biosimilar medicines and intellectual property, Deputy Health Minister Hani al-Oqabi explained that the agreement reached with Sanofi is not [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-51","post","type-post","status-publish","format-standard","hentry","category-non-classe"],"_links":{"self":[{"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/posts\/51","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/comments?post=51"}],"version-history":[{"count":1,"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/posts\/51\/revisions"}],"predecessor-version":[{"id":52,"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/posts\/51\/revisions\/52"}],"wp:attachment":[{"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/media?parent=51"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/categories?post=51"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/opellahealthcare.us\/index.php\/wp-json\/wp\/v2\/tags?post=51"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}